Authors: JUNG R KRUGER W HOSCH S HOLWEG M KROGER N GUTENSOHN K WAGENER C NEUMAIER M ZANDER AR

Citation: R. Jung et al., SPECIFICITY OF REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION ASSAYSDESIGNED FOR THE DETECTION OF CIRCULATING CANCER-CELLS IS INFLUENCED BY CYTOKINES IN-VIVO AND IN-VITRO, British Journal of Cancer, 78(9), 1998, pp. 1194-1198

Authors: YAMAUCHI H ONEILL A GELMAN R CARNEY W TENNEY DY HOSCH S HAYES DF

Citation: H. Yamauchi et al., PREDICTION OF RESPONSE TO ANTIESTROGEN THERAPY IN ADVANCED BREAST-CANCER PATIENTS BY PRETREATMENT CIRCULATING LEVELS OF EXTRACELLULAR DOMAIN OF THE HER-2 C-NEU PROTEIN/, Journal of clinical oncology, 15(7), 1997, pp. 2518-2525

Authors: PASSLICK B PANTEL K STOSIEK P HOSCH S THETTER O IZBICKI JR

Citation: B. Passlick et al., EXPRESSION OF PLAKOGLOBIN IN LUNG-CANCER - FREQUENCY AND PROGNOSTIC-SIGNIFICANCE, Langenbecks Archiv fur Chirurgie, 1996, pp. 810-813

Authors: GEISLER J EKSE D HOSCH S LONNING PE

Citation: J. Geisler et al., INFLUENCE OF DROLOXIFENE (3-HYDROXYTAMOXIFEN), 40 MG DAILY, ON PLASMAGONADOTROPINS, SEX-HORMONE BINDING GLOBULIN AND ESTROGEN-LEVELS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of steroid biochemistry and molecular biology, 55(2), 1995, pp. 193-195